Sallie Mae called its second quarter the low point for margins. The third-quarter report is the first chance to check that claim, and the numbers will need to support it. The lender is defending full-year guidance it has reaffirmed twice. That outlook now depends on a strong second half, after a first half that delivered $1.54 a share in the first quarter and only $0.29 in the second.
Wall Street expects $0.12 a share on revenue of about $353.7 million, down roughly 81% and 46% from the year-ago quarter. Those are steep declines, though the Street seems to be pricing in timing and accounting effects more than a collapse in the franchise. Full-year consensus of $3.16 sits near the middle of management's $3.10 to $3.20 range. The arithmetic is worth noting. With about $1.83 earned through June and only $0.12 expected now, the Street is counting on a very large fourth quarter. Anything that weakens confidence in that final stretch matters more than a few cents of variance in this print.
Net interest margin is the first test. It fell to 4.75% from 5.29% as the company held excess liquidity after its March loan sale, and net interest income dropped to $333 million from $375 million. Management linked the second-half recovery to putting that cash to work in peak-season disbursements and lifting margin back toward roughly 5%. A clear move up from 4.75% would support the transition-quarter story. A flat reading would suggest the drag is lasting longer than promised. Expenses matter too. The efficiency ratio jumped to 48.6% on one-time spending tied to PLUS reform, and investors should see whether that cost hump is easing.
Demand was the bright spot last quarter. Management said applications for its medical, dental, law and MBA products and its new parent loan were tracking at the high end of expectations or better. This report should show whether those applications turned into disbursed loans, which is the first real evidence behind the $4.5 billion to $5 billion annual opportunity tied to PLUS reform. Strong originations can still weigh on earnings in the near term, because new loans require upfront reserves. A heavier provision driven by growth would read very differently from one driven by worsening credit. The second strategic partnership, expected to close in the third quarter or early fourth, is another marker. A signed deal, especially one that widens the credit box or adds graduate lending, would add support to the growth narrative.
Credit is the newer worry. Some borrowers have been moving straight from delinquency to default with help from third-party debt-resolution firms. Sallie Mae stopped selling defaulted debt and brought recoveries in-house. Management described the resulting $25 million recovery headwind as a timing issue, and it raised the low end of its charge-off guidance to $365 million while holding the top at $385 million. Charge-offs that stay inside that range would support the timing argument. Pressure toward the upper end, or signs the problem is spreading, would challenge it.
The market has turned more skeptical. Shares are down about 1.3% since the last report while the S&P 500 gained 5.4%. Sentiment has grown more bearish, deepening to about -37% from roughly -20% a quarter ago. At $22.70, the stock trades below its 200-day average of $24.01 and near the bottom of a post-earnings range that peaked at $28.27. That sets a low bar for tone, but not for substance. The core question is whether margin recovery, peak-season disbursements and contained charge-offs together make the large fourth quarter needed to deliver guidance look credible.